ERCC3 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

16 results for “ERCC3”

Trials

View all 13 →

ERCC1 Targeted Trial

648 participants · First posted Dec 3, 2008

Gemcitabine and Oxaliplatin in the Management of Metastatic Pancreatic Cancers With Low Expression of ERCC1

First posted Feb 2, 2012

Exploratory Study Of The ERCC-1 Gene

64 participants · First posted Feb 18, 2009

Drugs

ERCC1/XPF nuclease inhibitors (cancer)

ERCC1-XPFinhibitors(University of Alberta)

News

FDA Clears Phase 1 Pediatric CNS Cancer Trial for STAR-001 Combination Therapy

Page 1 of 2